Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Population Pharmacokinetics of Acyclovir in Children and Young People with Malignancy after Administration of Intravenous Acyclovir or Oral Valacyclovir
Antimicrobial Agents and Chemotherapy, 06/30/09
Zeng L et al. - Acyclovir is effective in the prevention and treatment of herpes simplex virus and varicella-zoster virus infections. This validated population pharmacokinetic model for acyclovir may be used to develop dosing guidelines for safe and effective antiviral therapy in young people with malignancy.
Related Articles
Long-Term Administration of Valacyclovir Reduces the Number of Epstein-Barr Virus (EBV)-Infected B Cells but Not the Number of EBV DNA Copies per B Cell in Healthy Volunteers ,
Journal of Virology, 11/09/09
Relevance Score: 84%
Do Either Corticosteroids or Antiviral Agents Reduce the Risk of Long-Term Facial Paresis in Patients with New-onset Bells Palsy
The Journal of Emergency Medicine, 10/23/09
Relevance Score: 80%
Incidence, Risk Factors, and Severity of Herpesvirus Infections in a Cohort of 121 Patients With Primary Dermatomyositis and Dermatomyositis Associated With a Malignant Neoplasm
Internet Source, 10/05/09
Relevance Score: 80%
Newer trends in the management of genital herpes
Indian Journal of Dermatology, Venereology and Leprology, 11/18/09
Relevance Score: 77%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
HIV Medicine, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
Transplant Infectious Disease, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


